My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$RHT {{ '2015-09-21T21:07:01+0000' | timeago}} • Announcement

The world's leading provider of open source solutions, $RHT today reported increase in 2Q16 total revenue of 13% in U.S. dollars and also had an increase of 12% in its EPS YoverY. "Strong execution in 2Q16 contributed to total revenue results that exceeded 21% YoverY growth on a constant currency basis," stated Jim, CEO.

User Bob Phil {{ '2016-12-08T15:14:43+0000' | timeago}}

$CIEN a good stock to look at for the longs. Consistent revenue increase over the past few quarters suggest steady improvement in profitability of the company, which bodes well for the future prospect. I’m going to add a few more to my portfolio, anticipating good $$$ gains !

User Don Wolters {{ '2016-12-08T00:51:44+0000' | timeago}}

Shareholder alert..!! Rosen Law Firm has commenced an investigation into potential securities claims of $UHS. Shareholders please visit for more info.

User Charles Elliston {{ '2016-12-08T00:03:55+0000' | timeago}}

Can we see "Made in the USA" label on iPhones in the near future? Heard that $AAPL is considering the idea of manufacturing iPhone in America.

User Nora Foster {{ '2016-12-08T00:00:35+0000' | timeago}}

People who are looking for a steady growth stock should take a look at $EME. This stock has never had a significant downfall in the last five years. Comfortably beats consensus target most of the time. Such potential, much wow!

User Amelita Yates {{ '2016-12-07T22:59:16+0000' | timeago}}

Looks like Creative Planning jumped on the bandwagon! Increased its stake by 91% in $EWBC. A lot of companies recently raised their stack too. I smell something’s cooking.

$GILD {{ '2016-12-08T16:04:54+0000' | timeago}} • Announcement

$GILD submitted a new drug application to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single tablet regimen containing sofosbuvir 400 mg, velpatasvir 100 mg, and voxilaprevir 100 mg for treatment of direct-acting antiviral experienced chronic hepatitis C virus (HCV)-infected patients.

$GD {{ '2016-12-08T16:02:08+0000' | timeago}} • Announcement

General Dynamics Bath Iron Works, a subsidiary of $GD, received a $59MM contract from the U.S. Navy for the continuation of Arleigh Burke-class (DDG 51) Lead Yard Services and Flight III Upgrade design efforts. This extends services work for Arleigh Burke-class ships through December 2017.

$LLY {{ '2016-12-08T15:58:53+0000' | timeago}} • Announcement

$LLY said the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, met its primary endpoint of reducing expression of Ki67, a biomarker of cell proliferation, after two weeks of treatment of early-stage breast cancer.

$CASY {{ '2016-12-08T15:57:19+0000' | timeago}} • Webcast

During 2Q17, in $CASY’s prepared food category, gross profit dollars rose 7.4% to $156.3MM. The company is optimistic about the growth in this category for the remainder of FY17 as it benefits from the continued implementation of pizza delivery stores and its major remodel program as well as new store openings.

$PBH {{ '2016-12-08T15:54:22+0000' | timeago}} • Announcement

$PBH agreed for sale of the DermoPlast brand to Moberg Pharma AB for $47.6MM in cash plus inventory. The transaction is expected to be completed during December 2016. On an annual basis, $PBH expects the financial impact from the sale of DermoPlast to represent about $12MM in net sales and about $0.06 in EPS.